← SynDRA

dactinomycin

SynDRA canonical compound SYN0041807 — structure-anchored drug synonym record

All known targets

• POLR2A
• DDR2
• GRB2
• Grb2
• NGLY1

Mechanisms of action (all sources)

• RNA polymerase inhibitor

Drug classes

• Protein Synthesis Inhibitors
• Nucleic Acid Synthesis Inhibitors
• Anti-Bacterial Agents
• Anti-Infective Agents
• Antibiotics, Antineoplastic
• Antineoplastic Agents
• Enzyme Inhibitors
• Actinomycin

ATC classes

• L01D · CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES

Cross-references

• PubChem CID: 2019
• ChEMBL: CHEMBL1554
• DrugBank: DB00970
• ChEBI: CHEBI:27666
• KEGG: D00214
• RxNorm: 3100
• Wikipedia: Dactinomycin
• TTD: D0P8IV
• LINCS BRD: BRD-K70578146

Synonyms

• Actinomycin D
• Actactinomycin A IV
• Actinomycin 7
• Chounghwamycin B
• Dactinomycin D
• Dilactone actinomycin D acid
• Dilactone actinomycindioic D acid
• meractinomycin
• Oncostatin K
• Dactinomycine
• Dactinomicina
• Actinomycin-d
• Actinomycin c1
• Actinomycin i1
• Actinomycin iv
• Actinomycin x1
• Dactinomycinum
• Dilactone actinomycin d acid
• Meractinomycin
• Oncostatin k
• GNF-PF-2290
• GNF-Pf-1977
• NCI-C04682
• NSC-3053
• Cosmegen
• Cosmegen lyovac
• ACT D
• ACTINOMYCIN D AMP
• Actinomycin A IV
• Actinomycin Aiv
• Actinomycin I
• Actinomycin-IV
• Actinomycin cl
• Actinomycin x i
• Antibiotic from Streptomyces parvullus
• D Actinomycin
• Dactinomyein d
• Dilactone actin omycindioic D acid

Reported adverse events

• Infection
• Myelosuppression
• Extravasation
• Hepatotoxicity